Hema-T: advanced tactical tourniquet for massive hemorrhage control
Quick and easy leasing tailored to your facility’s needs. learn more>
Hema-T is a breakthrough solution in emergency and tactical medicine designed for the rapid control of hemorrhages from upper and lower extremities. In situations where seconds count, the Hema-T™ tourniquet offers unprecedented application speed and occlusion effectiveness to minimize the risk of death from exsanguination. Due to its unique design, the device sets new standards in “Stop the Bleed” programs by ensuring reliability in the hands of both professionals and first responders.
Unprecedented application speed
Time is of the essence—Hema-T allows for full tourniquet application in under 30 seconds. Compared to standard solutions, application takes as little as 5 seconds on the arm and up to 20 seconds on the leg, making it the fastest tool in its class.
Visual confirmation of effectiveness
The innovative design of Hema-T offers immediate visual feedback. A change in skin color below the application site indicates proper vascular occlusion, giving the rescuer confidence that the bleeding has been effectively stopped.
Optimal pressure distribution
The unique construction of the tourniquet ensures uniform pressure around the entire circumference of the limb. This minimizes the risk of additional tissue and nerve damage which often occurs when using narrow, traditional tourniquets.
Circulatory and resuscitation support
Hema-T does more than just control wounds; it provides support for the entire circulatory system. The device raises systolic and diastolic pressure while improving coronary and cerebral perfusion. It is fully compatible with resuscitation protocols and does not interfere with chest compressions or defibrillation.
Global trust
Hema-T technology and HemaShock circulatory support systems were developed and verified by leading medical units worldwide:
- Israel Defense Forces
Developed in collaboration with combat medicine experts.
- MADA (Israel’s National EMS)
Effectiveness confirmed by research within ambulatory rescue systems.
- São Paulo, Brazil
An official part of the emergency protocol for the São Paulo metropolitan area.
- Slovenia and Israel
Ongoing clinical trials at Beilinson Hospital confirming peak reliability.
| Application time (arm): | Up to 5 seconds |
|---|---|
| Application time (leg): | Up to 20 seconds |
| Operation: | Single-person (including self-aid) |
| Feedback: | Visual (change in skin color) |
| Impact on CPR: | No interference, increased perfusion |
